CRU 5002 | Universitätsmedizin Göttingen

JavaScript scheint in Ihrem Browser deaktiviert zu sein. Sie müssen JavaScript in Ihrem Browser aktivieren um alle Funktionen der Seite nutzen zu können.

Search

You are searching within UniversitätsKrebszentrum Göttingen.

Looking for information within the main UMG-Website.

Emergency call
112
Central accident and emergency department
Surgical accidents and emergencies
+49 (0)551 398604 (24 hours) +49 (0)551 3966105 (surgical ambulance)
Paediatric emergency ambulance
+49 (0)551 3966210 (24 hours)
Poison control centre north

Pancreatic ductal adenocarcinoma (PDAC) remains a major challenge in cancer medicine. The aggressive tumor biology and remarkable resistance to conventional anti-tumor treatments are reflected in a 5-year PDAC survival rate of less than 8%. Despite significant scientific and clinical efforts the dismal prognosis of PDAC has remained unchanged for almost 30 years, and PDAC has been predicted to become the second leading cause of cancer related death within this decade.

Our Clinical Research Unit 5002 (CRU 5002) focuses on defined molecular subgroups of PDAC and explores subtype-specific genome dynamics and their implications on PDAC progression and therapy resistance. We believe that our findings can provide unique and novel avenues to refine PDAC treatment strategies towards stratification-based precision medicine, thus improving the outcome of PDAC patients.

About the CRU 5002

Projects and contact information

Our Concept

The CRU 5002 aims at improving our understanding of subtype specificity in PDAC biology and therapy resistance and at creating solid foundations for stratification-based tailored treatment strategies in PDAC.

Scientific and Central Projects

Our projects aim at defining the mechanisms, functional relevance and therapeutic potential of altered genome dynamics in selected PDAC subtypes.

Our Team

All of the CRU 5002's staff at a glance. If you require any further information regarding the CRU 5002, please do not hesitate to contact us.

Events

KFO 5002 Seminar Series

11.12.2024, 2:00pm: Progress Update SP1

18.12.2024, 2:00pm: Progress Update SP7

Contact information

Contact persons at a glance

Speaker

Prof. Dr. med. Volker Ellenrieder

Prof. Dr. med. Volker Ellenrieder

contact information

e-mail address: kfo5002(at)med.uni-goettingen.de

secretariat

telephone: +49 551 3968020
fax: +49 551 3968023
e-mail address: ccc(at)med.uni-goettingen.de

Head of the Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology

Coordinator

Prof. Dr. med. Elisabeth Heßmann

contact information

telephone: +49 551 3962616
e-mail address: elisabeth.hessmann(at)med.uni-goettingen.de

Scientific Assistant

Alexander Müller

Alexander Müller

contact information

e-mail address: kfo5002(at)med.uni-goettingen.de

Follow us